Cargando…
Prior use of anticoagulation is associated with a better survival in COVID-19
Coronavirus disease 2019 (COVID-19) is associated with a high incidence of venous and arterial thromboembolic events. The role of anticoagulation (AC) prior to hospital admission and how different types of oral AC influences the outcome of COVID-19 is currently unknown. This observational study comp...
Autores principales: | Buenen, A. G., Sinkeldam, Marijn, Maas, Martje L., Verdonschot, Martha, Wever, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166893/ https://www.ncbi.nlm.nih.gov/pubmed/34061283 http://dx.doi.org/10.1007/s11239-021-02486-4 |
Ejemplares similares
-
Characteristics of chest pain in COVID-19 patients in the emergency department
por: Sinkeldam, M., et al.
Publicado: (2022) -
Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: A propensity score‐matched cohort study
por: Spiegelenberg, Janneke P., et al.
Publicado: (2021) -
Community-acquired bacteraemia in COVID-19 in comparison to influenza A and influenza B: a retrospective cohort study
por: Thelen, Julinha M., et al.
Publicado: (2021) -
552. Could Anticoagulant Use Prior to Infection with COVID-19 Decrease Mortality?
por: Natali, Kayla M, et al.
Publicado: (2020) -
THE ASSOCIATION OF ANTICOAGULATION BEFORE ADMISSION AND SURVIVAL OF PATIENTS WITH COVID-19
por: Kuno, Toshiki, et al.
Publicado: (2021)